Boston Scientific Q2 Adjusted Earnings, Revenue Rise; Lowers 2026 Guidance

MT Newswires Live

Jul 29

Boston Scientific (BSX) reported Q2 adjusted earnings Wednesday of $0.86 per share, up from $0.75 a year earlier.

Analysts polled by FactSet expected $0.83.

Net sales for the quarter ended June 30 were $5.44 billion, up from $5.06 billion a year earlier.

Analysts surveyed by FactSet expected $5.36 billion.

For Q3, the company expects adjusted EPS of $0.80 to $0.82 and net sales growth of 3% to 5%. Analysts polled by FactSet expect $0.84 and $5.38 billion, respectively.

For 2026, the company lowered its adjusted EPS guidance to $3.28 to $3.32 from $3.34 to $3.41. Analysts polled by FactSet expect $3.36.

Full-year net sales are now expected to grow about 5.5% to 6.5%, down from the previous projection of 7% to 8.5% growth.

Shares of the company were up 3.5% in Wednesday's premarket activity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/2655861634"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2655861634\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2655861634?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-29 18:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2655861634","market":"sg","top_or_hot":-1,"title":"Boston Scientific Q2 Adjusted Earnings, Revenue Rise; Lowers 2026 Guidance","media":"MT Newswires Live","content":"<html><body><p> Boston Scientific (BSX) reported Q2 adjusted earnings Wednesday of $0.86 per share, up from $0.75 a year earlier.</p><p>Analysts polled by FactSet expected $0.83.</p><p>Net sales for the quarter ended June 30 were $5.44 billion, up from $5.06 billion a year earlier.</p><p>Analysts surveyed by FactSet expected $5.36 billion.</p><p>For Q3, the company expects adjusted EPS of $0.80 to $0.82 and net sales growth of 3% to 5%. Analysts polled by FactSet expect $0.84 and $5.38 billion, respectively.</p><p>For 2026, the company lowered its adjusted EPS guidance to $3.28 to $3.32 from $3.34 to $3.41. Analysts polled by FactSet expect $3.36.</p><p>Full-year net sales are now expected to grow about 5.5% to 6.5%, down from the previous projection of 7% to 8.5% growth.</p><p>Shares of the company were up 3.5% in Wednesday's premarket activity.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Boston Scientific Q2 Adjusted Earnings, Revenue Rise; Lowers 2026 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBoston Scientific Q2 Adjusted Earnings, Revenue Rise; Lowers 2026 Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-29 18:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Boston Scientific (BSX) reported Q2 adjusted earnings Wednesday of $0.86 per share, up from $0.75 a year earlier.</p><p>Analysts polled by FactSet expected $0.83.</p><p>Net sales for the quarter ended June 30 were $5.44 billion, up from $5.06 billion a year earlier.</p><p>Analysts surveyed by FactSet expected $5.36 billion.</p><p>For Q3, the company expects adjusted EPS of $0.80 to $0.82 and net sales growth of 3% to 5%. Analysts polled by FactSet expect $0.84 and $5.38 billion, respectively.</p><p>For 2026, the company lowered its adjusted EPS guidance to $3.28 to $3.32 from $3.34 to $3.41. Analysts polled by FactSet expect $3.36.</p><p>Full-year net sales are now expected to grow about 5.5% to 6.5%, down from the previous projection of 7% to 8.5% growth.</p><p>Shares of the company were up 3.5% in Wednesday's premarket activity.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSX","symbol_name":"波士顿科学","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2655861634","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2655861634","pubTimestamp":1785322131,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Boston Scientific  reported Q2 adjusted earnings Wednesday of $0.86 per share, up from $0.75 a year earlier.Analysts polled by FactSet expected $0.83.Net sales for the quarter ended June 30 were $5.44 billion, up from $5.06 billion a year earlier.Analysts surveyed by FactSet expected $5.36 billion.For Q3, the company expects adjusted EPS of $0.80 to $0.82 and net sales growth of 3% to 5%. Analysts polled by FactSet expect $0.84 and $5.38 billion, respectively.For 2026, the company lowered its adjusted EPS guidance to $3.28 to $3.32 from $3.34 to $3.41. Analysts polled by FactSet expect $3.36.Full-year net sales are now expected to grow about 5.5% to 6.5%, down from the previous projection of 7% to 8.5% growth.Shares of the company were up 3.5% in Wednesday's premarket activity.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BSX":"波士顿科学"},"translate_title":"波士顿科学第二季度调整收益，收入增长；降低 2026 年指引","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSX":1.5},"content_text":"Boston Scientific (BSX) reported Q2 adjusted earnings Wednesday of $0.86 per share, up from $0.75 a year earlier.Analysts polled by FactSet expected $0.83.Net sales for the quarter ended June 30 were $5.44 billion, up from $5.06 billion a year earlier.Analysts surveyed by FactSet expected $5.36 billion.For Q3, the company expects adjusted EPS of $0.80 to $0.82 and net sales growth of 3% to 5%. Analysts polled by FactSet expect $0.84 and $5.38 billion, respectively.For 2026, the company lowered its adjusted EPS guidance to $3.28 to $3.32 from $3.34 to $3.41. Analysts polled by FactSet expect $3.36.Full-year net sales are now expected to grow about 5.5% to 6.5%, down from the previous projection of 7% to 8.5% growth.Shares of the company were up 3.5% in Wednesday's premarket activity.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}